cis-2-(1-Mercapto-1-methylethyl)-5-methylcyclohexan-1-one
Common Name: |
cis-2-(1-Mercapto-1-methylethyl)-5-methylcyclohexan-1-one |
IUPAC Name: |
(2R,5S)-5-methyl-2-(2-sulfanylpropan-2-yl)cyclohexan-1-one |
Molecular Formula: |
C10H18OS |
SMILES: |
CC1CCC(C(=O)C1)C(C)(C)S |
Inchi: |
1S/C10H18OS/c1-7-4-5-8(9(11)6-7)10(2,3)12/h7-8,12H,4-6H2,1-3H3/t7-,8+/m0/s1 |
Inchi Key: |
RVOKNSFEAOYULQ-JGVFFNPUSA-N |
Cas No: |
35117-86-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
186.31 |
Mass (g/mol) |
186.108 |
Molar Refractivity |
56.24 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
55.87 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
273.09 |
Vapor Pressure (mmHg@25.00 °C) |
0.006 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
2.7 |
iLOGP |
2.42 |
XLOGP3 |
2.31 |
WLOGP |
2.70 |
MLOGP |
2.30 |
ESOL Log S |
-2.38 |
ESOL Solubility (mg/ml) |
0.769 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.12 |
Ali Solubility (mg/ml) |
0.14 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.30 |
Silicos-IT Solubility (mg/ml) |
0.94 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.80 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.776 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.603 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |